Q2 Shows No Hint of Deterioration at salesforce.com (CRM) - Needham & Company
Needham & Company analyst Michael Huang reiterated a Buy rating and $50 price target on salesforce.com (NYSE: CRM) following solid ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
